Esketamine, administered as a nasal spray, is a cousin of the anesthetic ketamine, which was once a popular recreational drug. Studies have shown ketamine's effectiveness against depression, ...

Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in combination with SSRIs and SNRIs, in treatment-resistant depression, a study found.

Use of esketamine and psychedelics like MDMA and psilocybin for depression and other mental health issues must come with a change in administering care. Skip to Main Content. diagnostics.

The chemical structure of esketamine. Some reports about esketamine have sensationalized this issue by referring to ketamine as a highly addictive street drug . In my research, this is not true.

Last week, the FDA announced that it had officially approved Spravato, a brand-name nasal spray containing esketamine, a chemical cousin of ketamine, to treat depression.The drug was hailed by ...

Amelia D. has been in an esketamine trial since 2017. Here's what it's like to take ketamine-derived esketamine, the new depression drug.

Media reports touting ketamine as a miracle drug for severe depression have contributed to confusion about the differences between ketamine and its esketamine, experts said.

After screening and randomization, 95 patients received 84 mg esketamine, 86 patients received 56 mg esketamine, and 197 received placebo. About 61% were female, 86.8% were white, and 65.6% were ...

Esketamine, the nasal-spray antidepressant recently approved by the F.D.A., is promising, but using it entails some practical challenges. By Benedict Carey Doctors welcomed federal approval this ...

This week, the FDA approved esketamine, the first nasal spray to treat depression in adults who have tried other antidepressant medications without success. Esketamine, which the FDA approved to ...